Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fezolinetant for menopausal hot flashes
NCT04003142Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Countries
- 7
01
Overview
A Phase 3 trial of fezolinetant in hot flashes, sponsored by Astellas Pharma. Started Jul 2019; status: completed.
02
Drugs
fezolinetant
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT04003142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003142.